| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 752.16 Million | USD 1660.31 Million | 8.24% | 2024 |
FrequentlyAsked Questions
The global drug-coated balloons market is expected to grow due to increasing prevalence of cardiovascular and peripheral artery diseases, the rising demand for minimally invasive procedures.
According to a study, the global drug-coated balloons market size was worth around USD 752.16 Million in 2024 and is expected to reach USD 1660.31 Million by 2034.
The global drug-coated balloons market is expected to grow at a CAGR of 8.24% during the forecast period.
North America is expected to dominate the drug-coated balloons market over the forecast period.
Leading players in the global drug-coated balloons market include Bayer AG, B. Braun SE, Eurocor GmbH, Biosensors International Group, Boston Scientific Corporation, iVascular, Medtronic plc, BIOTRONIK, Caliber Therapeutics, Concept Medical Research, among others.
The report explores crucial aspects of the drug-coated balloons market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients